Events & Presentations



The Catasys team comprises doctors, nurses and business professionals with extensive experience in BH and a passion for alleviating the suffering of individuals with coexisting behavioral and medical conditions. As thought leaders in health care, our staff has published books, papers and studies relating to BH and predictive modeling. Catasys is known for translating proven science into practice quickly, and its proprietary methodology in understanding and engaging members who need treatment. Catasys, Inc. stock is traded on NASDAQ under the symbol CATS.


Corporate Presentation

Except for statements of historical fact, the matters presented in this presentation are forward-looking and made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements reflect numerous assumptions and involve a variety of risks and uncertainties, many of which are beyond our control that may cause actual results to differ materially from stated expectations. Download presentation below to read full Forward-Looking Statements and Company.

27-Apr-2017 Download Presentation (PDF) Download Presentation (PDF)

Stock News Now -- LD Micro Conference

Terren Peizer, Catasys’ Chairman of the Board and CEO


------------
HLN The Daily Share

Catasys' SVP and CMO, Omar Manejwala, M.D., FASAM, DFAPA


------------
CNN New Day

Catasys' SVP and CMO, Omar Manejwala, M.D., FASAM, DFAPA


------------
NBT Equities Research

Top 100 Emerging Growth Microcap Companies for 2013

05/02/17
Catasys to Participate in Joseph Gunnar's Pioneers 2017 Conference on May 2, 2017
Terren Peizer, Chairman of the Board and Chief Executive Officer
Joseph Gunnar's Pioneers 2017 Conference on Mandarin Oriental Hotel in New York City on Tuesday, May 2, 2017 at 10:00 am ET
For more information and registration, please visit the conference website.

------------
04/27/17
Catasys to Present at RedChip’s Global Online Growth Conference on April 27, 2017
Terren Peizer, Chairman of the Board and Chief Executive Officer
RedChip’s Global Online Growth Conference on Thursday, April 27, 2017 at 3:00 p.m. ET
The presentation can be viewed at www.RedChip.com. A live Q&A session will follow the investor presentation.

------------
03/15/17
Catasys to Participate in the 29th Annual ROTH Conference on March 15, 2017
Terren Peizer, Chairman of the Board and Chief Executive Officer
The Ritz-Carlton, Laguna Niguel in Dana Point, CA on Wednesday, March 15, 2017 at 8:30 am PT / 11:30 am ET
For more information and registration, please visit the conference website.

------------
10/08/16
Catasys to Participate in the IntNSA 2016 Annual Educational Conference
Omar Manejwala, M.D., FASAM, DFAPA, Catasys' SVP and CMO and Kristie Wolbers, RN, BSN, Catasys' Director of Clinical Integration
The Westin Hotel in Las Vegas on Saturday, October 8, 2016 at 10:30 am PT
For more information, please visit the conference website.

------------
09/22/16
Catasys to Participate in Aegis Capital 2016 Annual Growth Conference
Terren Peizer, Catasys’ Chairman of the Board and CEO
The Encore Hotel in Las Vegas on Thursday, September 22, 2016 at 10:00 am PT
For more information and registration, please visit the conference website.

------------
06/07/16
Catasys to Participate in LD Micro Invitational
Terren Peizer, Catasys’ Chairman of the Board and CEO
Luxe Sunset Bel Air; Los Angeles; Tuesday, June 7, 2016; 12:00 pm PT
For more information and registration, please visit the conference website.

------------
05/05/16
Catasys to Participate in Joseph Gunnar's Pioneers 2016 Conference
Terren Peizer, Catasys’ Chairman of the Board and CEO
New York Palace Hotel, NYC; May 5, 2016; 2:00 pm ET
For more information and registration, please visit the conference website.

------------
04/29/16
Second Annual Oklahoma Association for the Treatment of Opioid Dependence (OKATOD) Conference
The Opioid Epidemic: How we got here; how to fix it.
Catasys' SVP and CMO, Omar Manejwala, M.D., FASAM, DFAPA
Oklahoma City, OK; April 29, 2016

------------
Catasys’ Chief Medical Officer, Omar Manejwala, M.D.
Humana-Catasys Case Study
Austin TX; April 23-26, 2015

------------
Catasys’ President and Chief Operating Officer, Richard Anderson
Tuesday, March 10, 2015
The Ritz-Carlton Laguna Niguel in Dana Point, California

------------
06/13/13
First Annual Singular Research’s Solstice Conference
Catasys’ President and Chief Operating Officer, Richard Anderson
Millennium Broadway Hotel, New York, NY

------------
Catasys’ Chief Medical Officer, Omar Manejwala, M.D.
Friday, April 26th, 2013; Hilton Chicago
"Combining Predictive Analytics, Outreach, evidence-based Treatment, Case Management and Monitoring to Generate Clinical Outcome Driven Cost Reductions in High Cost Substance Dependent Populations."

Print

By Omar Manejwala, M.D.
Omar Manejwala, M.D. is the Senior Vice President and Chief Medical Officer of Catasys. Dr. Manejwala is a transformative public speaker and appears frequently in the national media to address the topic of addiction.

Web

Rethink Treatment Models for Substance Dependence
June 1, 2010; Managed Healthcare Executive
By Gary Ingenito, M.D., Ph.D